![Brian Corvese](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brian Corvese
Direktor/Vorstandsmitglied bei
AGENUS INC.
Vermögen: 592 469 $ am 31.07.2026
Profil
Mr. Brian J.
Corvese is an Independent Non-Executive Director at Protagenic Therapeutics, Inc., an Independent Director at MiNK Therapeutics, Inc., an Independent Director at Agenus, Inc. and a President at Vencor Capital (Pty ) Ltd. He is on the Board of Directors at Protagenic Therapeutics, Inc., MiNK Therapeutics, Inc., Agenus, Inc. and National Telecommunications Corp.
Mr. Corvese was previously employed as a Portfolio Manager & Partner by Chancellor Capital Management, Inc. and a Managing Director & Partner by Soros Fund Management LLC.
He received his undergraduate degree from the University of Rhode Island.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MINK THERAPEUTICS, INC. 1,07 % | 01.06.2026 | 53.137 ( 1,07 % ) | 557 939 $ | 31.07.2026 |
AGENUS INC. 0,01 % | 24.04.2026 | 4.604 ( 0,01 % ) | 34 530 $ | 31.07.2026 |
| 30.11.2025 | 0 ( -.--% ) | - $ | 31.07.2026 |
Aktive Positionen von Brian Corvese
| Unternehmen | Position | Beginn |
|---|---|---|
| AGENUS INC. | Direktor/Vorstandsmitglied | 08.03.2007 |
| PROTAGENIC THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 28.07.2017 |
| MINK THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.07.2017 |
National Telecommunications Corp.
 National Telecommunications Corp. Miscellaneous Commercial ServicesCommercial Services Provides information services for business, electronic commerce, and circuit boards manufacturing. | Direktor/Vorstandsmitglied | - |
Vencor Capital (Pty ) Ltd. | Gründer | 01.01.1999 |
Ehemalige bekannte Positionen von Brian Corvese
| Unternehmen | Position | Ende |
|---|---|---|
Chancellor Capital Management, Inc.
 Chancellor Capital Management, Inc. Investment ManagersFinance Investment advisors | Corporate Officer/Principal | 01.01.1996 |
Soros Fund Management LLC
 Soros Fund Management LLC Investment ManagersFinance SFM aims to protect and grow Open Society’s resources. The firm invests globally in a wide range of strategies and asset classes, including public equities, fixed income, commodities, foreign exchange, alternative assets and private equity. | Corporate Officer/Principal | - |
Ausbildung von Brian Corvese
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
61
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Chancellor Capital Management, Inc.
Chancellor Capital Management, Inc. Investment ManagersFinance Investment advisors | Finance |
Soros Fund Management LLC
Soros Fund Management LLC Investment ManagersFinance SFM aims to protect and grow Open Society’s resources. The firm invests globally in a wide range of strategies and asset classes, including public equities, fixed income, commodities, foreign exchange, alternative assets and private equity. | Finance |
Agenus, Inc.
 Agenus, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of technologies to treat cancers and infectious diseases | Health Technology |
University of Rhode Island
 University of Rhode Island Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Telecommunications Corp.
National Telecommunications Corp. Miscellaneous Commercial ServicesCommercial Services Provides information services for business, electronic commerce, and circuit boards manufacturing. | Commercial Services |
Vencor Capital (Pty ) Ltd. | |
Protagenic Therapeutics, Inc.
 Protagenic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company that engages in discovery and development of therapeutics to treat stress-related neuropsychiatric & mood disorders | Health Technology |
MiNK Therapeutics, Inc.
 MiNK Therapeutics, Inc. BiotechnologyHealth Technology Provides bio pharmaceutical services | Health Technology |
